Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition

The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers

(2012) Suping Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

Single Molecular Recognition Force Spectroscopy Study of a Luteinizing Hormone-Releasing Hormone Analogue as a Carcinoma Target Drug

(2012) Jing Zhang et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Imaging and Measuring the Molecular Force of Lymphoma Pathological Cells Using Atomic Force Microscopy

(2012) Mi Li et al.   SCANNING

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy

(2012) Guilly Rebagay et al.   Frontiers in Oncology

Rituximab resistance

(2011) Andrew R. Rezvani et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

The future of anti-CD20 monoclonal antibodies: are we making progress?

(2011) W. Alduaij et al.   BLOOD

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Detecting CD20-Rituximab interaction forces using AFM single-molecule force spectroscopy

(2011) Mi Li et al.   CHINESE SCIENCE BULLETIN

Biological AFM: where we come from - where we are - where we may go

(2011) Ignacio Casuso et al.   JOURNAL OF MOLECULAR RECOGNITION

Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)

(2011) Sabrina Uhrmacher et al.   LEUKEMIA RESEARCH

Five challenges to bringing single-molecule force spectroscopy into living cells

(2011) Yves F Dufrêne et al.   NATURE METHODS

Atomic Force Microscopy-Based Molecular Recognition of a Fibrinogen Receptor on Human Erythrocytes

(2010) Filomena A. Carvalho et al.   ACS Nano

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

(2010) M. Hudecek et al.   BLOOD

ROR1 expression is not a unique marker of CLL

(2010) Gábor Barna et al.   HEMATOLOGICAL ONCOLOGY

HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells

(2010) R Shimizu et al.   LEUKEMIA

Evolution of anti- CD20 monoclonal antibody therapeutics in oncology

(2010) Ezogelin Oflazoglu et al.   mAbs

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Anti-CD20 monoclonal antibodies: historical and future perspectives

(2009) S. H. Lim et al.   HAEMATOLOGICA

Fishing single molecules on live cells

(2009) Vincent Dupres et al.   Nano Today

Force probing surfaces of living cells to molecular resolution

(2009) Daniel J Müller et al.   Nature Chemical Biology

The cancer biomarker problem

(2008) Charles L. Sawyers   NATURE

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

(2008) Bruce D. Cheson et al.   NEW ENGLAND JOURNAL OF MEDICINE